When used in combination with other available therapies for the treatment of patients with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) breast cancer (HR+/HER2− advanced breast cancer) give hope in search for the cure against this deadly disease [216]. Here, ERBB2 is linked to breast carcinoma.